Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | |
---|---|---|---|
Cost-effectiveness of pembrolizumab compared to ipilimumab and chemotherapy as a first line treatment for patients with advanced melanoma in Hong Kong Proceeding/Conference:Annals of Oncology | 2016 | ||
Single-nucleotide polymorphism (SNP) of excision repair cross complementation group 1 (ERCC1) in nasopharynx cancer (NPC): A companion biomarker study to Hong Kong NPC Study Group 0502 trial Proceeding/Conference:American Society of Clinical Oncology (ASCO) Annual Meeting 2014 | 2014 |